Black Rock Inc. Axcella Health Inc. Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.22 - $0.46 $11,333 - $23,696	-51,515 Reduced 17.2%	247,915 $54,000
Q1 2023 May 12, 2023	BUY	$0.31 - $0.77 $515 - $1,279	1,662 Added 0.56%	299,430 $143,000
Q4 2022 Feb 13, 2023	BUY	$0.16 - $1.1 $177 - $1,218	1,108 Added 0.37%	297,768 $98,000
Q3 2022 Nov 14, 2022	SELL	$1.62 - $2.73 $2,243 - $3,781	-1,385 Reduced 0.46%	296,660 $507,000
Q2 2022 Aug 12, 2022	BUY	$1.41 - $2.77 $2,862 - $5,623	2,030 Added 0.69%	298,045 $606,000
Q1 2022 May 12, 2022	SELL	$1.58 - $2.82 $3,938 - $7,030	-2,493 Reduced 0.84%	296,015 $761,000
Q4 2021 Feb 10, 2022	BUY	$2.06 - $3.61 $4,799 - $8,411	2,330 Added 0.79%	298,508 $625,000
Q3 2021 Nov 09, 2021	SELL	$2.98 - $4.31 $3,301 - $4,775	-1,108 Reduced 0.37%	296,178 $883,000
Q2 2021 Aug 11, 2021	BUY	$3.08 - $5.13 $915,640 - $1.53 Million	297,286 New	297,286 $1.19 Million

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.